Register now banner
Woman working on laptop

Say Yes to register now

Say yes to register now
Not an actual patient.

Sign up now to stay informed.

*All fields required

First Name required
Last Name required
Email Address required Invalid Email Address
Zip Code required

I confirm that I have read the Viatris Privacy Notice at www.viatris.com/en/privacy-policy and agree that Viatris Inc., its affiliates and subsidiaries (“Viatris”) may use my personal data to provide me with scientific information and information on pharmaceutical products as well as events, webinars or surveys. I understand and acknowledge that all information processed by Viatris is handled in accordance with local privacy laws and may be captured and processed in countries outside of the jurisdiction in which it was collected. In order to improve its emails, websites and information services, Viatris may track whether I received an email, opened it, clicked on any links, viewed or downloaded any documents within it. I understand that my consent is voluntary and I can withdraw my consent at any time. The withdrawal of consent will not affect the lawfulness of processing my personal information based on my consent prior to its withdrawal. I acknowledge that I am not obliged to provide my personal information. However, if I do not provide the information, I may not, for example, be able to participate fully in activities managed by Viatris.

Thank you for signing up!

PATIENT MEDICATION INFORMATION

GLATIRAMER ACETATE INJECTION 20 mg/mL (once-daily) is used to treat patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including those who have experienced one episode of nervous system symptoms and who have abnormalities on their brain scan that may be the first signs of Multiple Sclerosis.

GLATIRAMER ACETATE INJECTION is not a cure. Patients treated with GLATIRAMER ACETATE INJECTION experience fewer relapses (flare-ups of the disease).

Do not use GLATIRAMER ACETATE INJECTION if: you are allergic to glatiramer or mannitol or the solution in the pre-filled syringe is cloudy, leaking or contains any particles.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take GLATIRAMER ACETATE INJECTION.

Talk about any health conditions or problems you may have, including if you: have heart disease; have a history of developing severe allergic reactions; have chronic obstructive pulmonary disease (COPD); have asthma; have kidney and or liver problems; are pregnant, planning to become pregnant, or if you become pregnant while you are using this medication; are nursing; are under 18 years of age.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

These are not all the possible side effects you may feel when taking GLATIRAMER ACETATE INJECTION. If you experience any side effects not listed here, contact your healthcare professional. The most common side effects of GLATIRAMER ACETATE INJECTION are: skin reactions at the injection site including redness, pain, inflammation, itching, swelling, lumps; permanent “dent” under the skin at the injection site, caused by damage to the fatty tissue at that site; rash; hives; headache; a feeling of worry, nervousness, unease (anxiety).

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by: Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice

If you want more information about GLATIRAMER ACETATE INJECTION: